Cargando…
Data-Driven Identification of Biomarkers for In Situ Monitoring of Drug Treatment in Bladder Cancer Organoids
Three-dimensional (3D) organoid culture recapitulating patient-specific histopathological and molecular diversity offers great promise for precision medicine in cancer. In this study, we established label-free imaging procedures, including Raman microspectroscopy (RMS) and fluorescence lifetime imag...
Autores principales: | Becker, Lucas, Fischer, Felix, Fleck, Julia L., Harland, Niklas, Herkommer, Alois, Stenzl, Arnulf, Aicher, Wilhelm K., Schenke-Layland, Katja, Marzi, Julia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266781/ https://www.ncbi.nlm.nih.gov/pubmed/35805961 http://dx.doi.org/10.3390/ijms23136956 |
Ejemplares similares
-
Effects of Scaffolds on Urine- and Urothelial Carcinoma Tissue-Derived Organoids from Bladder Cancer Patients
por: Walz, Simon, et al.
Publicado: (2023) -
A Protocol for Organoids from the Urine of Bladder Cancer Patients
por: Walz, Simon, et al.
Publicado: (2023) -
CD24: A Marker for an Extended Expansion Potential of Urothelial Cancer Cell Organoids In Vitro?
por: Geng, Ruizhi, et al.
Publicado: (2022) -
Urinary Tract Tumor Organoids Reveal Eminent Differences in Drug Sensitivities When Compared to 2-Dimensional Culture Systems
por: Wei, Yi, et al.
Publicado: (2022) -
Large Animal Models for Investigating Cell Therapies of Stress Urinary Incontinence
por: Amend, Bastian, et al.
Publicado: (2021)